Search details
1.
The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components.
Cell Microbiol
; 21(5): e13000, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30578712
2.
The Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.
J Immunol
; 196(3): 1177-85, 2016 Feb 01.
Article
in English
| MEDLINE | ID: mdl-26695372
3.
Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils.
J Immunol
; 191(9): 4748-58, 2013 Nov 01.
Article
in English
| MEDLINE | ID: mdl-24068665
4.
Detection of Cleaved Stx2a in the Blood of STEC-Infected Patients.
Toxins (Basel)
; 15(12)2023 12 08.
Article
in English
| MEDLINE | ID: mdl-38133194
5.
Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.
J Biol Chem
; 286(40): 34514-21, 2011 Oct 07.
Article
in English
| MEDLINE | ID: mdl-21832076
6.
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells.
J Cell Biochem
; 113(4): 1132-41, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22095559
7.
Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.
Reproduction
; 143(4): 455-68, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22274885
8.
Efficient isolation and enrichment of mesenchymal stem cells from bone marrow.
Cytotherapy
; 14(6): 686-93, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22574721
9.
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients.
Front Immunol
; 13: 1058739, 2022.
Article
in English
| MEDLINE | ID: mdl-36713433
10.
Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies.
J Cell Biochem
; 112(5): 1418-30, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21321995
11.
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.
Retrovirology
; 8: 40, 2011 May 25.
Article
in English
| MEDLINE | ID: mdl-21612582
12.
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.
Haematologica
; 96(1): 128-33, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20935000
13.
A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
Cytotherapy
; 13(5): 523-7, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21171826
14.
Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor.
Biochem J
; 432(1): 173-80, 2010 Nov 15.
Article
in English
| MEDLINE | ID: mdl-20809900
15.
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies.
Res Pract Thromb Haemost
; 5(8): e12606, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34938937
16.
A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia Vera.
Cancers (Basel)
; 13(19)2021 Oct 02.
Article
in English
| MEDLINE | ID: mdl-34638452
17.
An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera.
Front Oncol
; 11: 715217, 2021.
Article
in English
| MEDLINE | ID: mdl-34900671
18.
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis.
Oncoimmunology
; 9(1): 1782575, 2020 06 23.
Article
in English
| MEDLINE | ID: mdl-32923146
19.
Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
Thromb Haemost
; 120(1): 107-120, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31858520
20.
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.
Br J Haematol
; 147(5): 710-8, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19764990